Health Cor Management, L.P. Dynavax Technologies Corp Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $32.7 Million - $55.8 Million	-4,613,280 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $16.9 Million - $27.7 Million	2,082,173 Added 82.26%	4,613,280 $42.2 Million
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $4.81 Million - $7.84 Million	-590,362 Reduced 18.91%	2,531,107 $38.6 Million
Q3 2018 Nov 15, 2018	BUY	$11.85 - $16.0 $7 Million - $9.45 Million	590,362 Added 23.32%	3,121,469 $38.7 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $18.4 Million - $25.2 Million	1,212,495 Added 91.95%	2,531,107 $38.6 Million
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $19.3 Million - $26.2 Million	1,318,612 New	1,318,612 $26.2 Million

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.